Ashishchandra Rao PARTNER

Overview

Ashishchandra Rao is a Partner in the Arbitration and Dispute Resolution Practice of ELP.

He has represented and advised domestic and international clientele in negotiations, mediations, court litigation and international commercial & domestic arbitrations. He has worked across sectors including drugs and cosmetics, legal metrology, real estate, electricity, insolvency and bankruptcy, debt recovery, infrastructure and construction, environment, information technology, finance and securities. He has a deep understanding, knowledge and experience of pre-dispute and litigation advisory and strategy.

Ashishchandra has extensive experience in court litigation at all levels and has represented clients up to the Supreme Court of India and has various reported judgments to his name. Ashish has also represented clients in ad-hoc and institutional arbitrations, including arbitrations under the Rules of ICC, SIAC, BSE and NSE. Ashish is also proficient in trial law and conducting complex evidentiary hearings.

Ashish has been recognized as Recommended for his expertise in arbitration by The Legal 500 Asia-Pacific.

Ashishchandra is enrolled with the Bar Council of Maharashtra and Goa. He is also a member of Young MCIA, Young SIAC and ICC Young Arbitrators Forum.

Recognitions

Legal500
    • Recommended Lawyer for Arbitration

Marketing Code for Pharmaceutical Companies gets tougher: A comparison of the 2024 and 2014 codes

18 Mar 2024 | Read More

New Regulations in Play at The Brink Of 2024: Enhancing Controls for Regulatory Entities And Alternative Investment Funds

10 Jan 2024 | Read More

Delhi High Court Judgment in Bharat Serums – a relief to Drug Manufacturers

29 Nov 2023 | Read More

Proposed NPC Bill to promote innovation & research in pharmacy: Experts

27 Nov 2023 | Read More

Quality Quagmire. Why drugmakers are dialing C for current good manufacturing practices

26 Nov 2023 | Read More

Resolving disputes with discretion: Analysing confidentiality in arbitration proceedings

28 Jul 2023 | Read More

For the Mighty Managing Director, vicarious criminal liability can be thy arch nemesis

12 Jul 2023 | Read More

Whale Of A Tale: Tracing The Centre’s Recent Ban On 14 FDCs Approved Prior To 1988

6 Jul 2023 | Read More

Regulatory Blindspot and Contradictions: Sale, Manufacturing and Price Regulation of India’s Medical Devices market

6 Jun 2023 | Read More

ELP Knowledge Series India Update Part 1 of 2023

12 Apr 2024 | Read More